CARE Series - Lethal Substances and Overdose Prevention

Friday, June 28, 2024, 12:00 PM - Monday, June 28, 2027, 1:00 PM

AMA PRA Category 1 Credits™ (1.00 hours), ANCC Nursing Contact Hours (1.00 hours), CME-Designated Participation Credit (1.00 hours)

Review of harm reduction strategies in general medical settings including:

• Promoting effective treatment of OUD
• Reducing stigma
• Meeting patients where they are
• Providing naloxone
• Counseling and facilitating safer substance use
• Connecting to good preventative primary care
• Engaging teams in good opioid stewardship

Presenter

Melissa Volansky, MD
Chief Medical Officer
Lamoille Health Partners
Morrisville, VT

Presenter Biography

As Chief Medical Officer of Lamoille Health Partners, Melissa Volansky, MD, brings the perspective of a clinician and physician executive to Lamoille Health Partners. She is respected by the Lamoille team for her achievements in defining strategic organizational goals that deliver quality outcomes. A physician at Stowe Family Practice since 1999, Dr. Volansky supports the clinical endeavors of the organization through leadership and coordination, while continuing to provide compassionate primary care to her own panel of patients. Dr. Volansky is an advocate for comprehensive family care focused on chronic disease as well as women’s health care. She utilizes a team-based approach to care for diverse patient populations, including those with complicated chronic illnesses such as diabetes, hypertension, and substance use disorders. A graduate of the University of Vermont College of Medicine, Dr. Volansky completed her family medicine residency at Highland Hospital within the University of Rochester Medical Center. Dr. Volansky is board certified through the American Board of Family Medicine and holds a VT State Medical License. An alumna of Stowe High School, Dr. Volansky takes pride in her 20 years of practicing family medicine in Stowe. Mother of two, she lives in Morrisville with her husband Shap, where they spend most of their free time cross-country skiing and keeping their cats company.

1. Summarize strategies for engaging patients in harm reduction reflective of patient stage of change.
2. List safer substance use practices including provision of naloxone and sterile syringes.
3. Locate harm reduction resources for patients and for providers.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Medical Association (AMA)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 ANCC contact hours.

All other learners may claim CME-designated participation credit. Consult your professional licensing board regarding the applicability and acceptance of CME-designated participation credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.
2. Register for the activity.
3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.
4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).
5. Click the Complete Evaluation button, or click My Account in the menu bar; then click Evaluations.
6. Complete and Submit the Evaluation.

Bibliographic Sources

• Addiction Medicine Podcast - The Curbsiders 
  
  
• Gathering Information About Substance Use | SOAR Works! (samhsa.gov)
  
  
• Home | Vermont CARES (vtcares.org)
  
  
• JHSPH Stigma Lab | Center for Mental Health and Addiction Policy (jhu.edu)
  
  
• Medications for Opioid Use Disorder (MOUD) - PCSS (pcssnow.org)
  
  
• NASEN | North America Syringe Exchange Network: NASEN Directory
  
  
• National Harm Reduction Coalition
  
  
• Never Use Alone Inc. – 800-484-3731
  
  
• Opioid Prescribing and MOUD | Vermont Department of Health (healthvermont.gov)
  Prescribing Syringes to Injection Drug Users: What the Family Physician Should Know | AAFP
  
  
• Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care - PMC (nih.gov)
  
  
• Safer Injection Practices for People who Inject Drugs (va.gov)
  
  
• SAMHSA Opioid Overdose Toolkit
  
  
• Substance Misuse Treatment Services | New Hampshire Department of Health and Human Services (nh.gov)
  
  
• Syringe Service Programs | Vermont Department of Health (healthvermont.gov)
  
  
• Syringe Service Programs in New Hampshire | New Hampshire Department of Health and Human Services (nh.gov)
  
  
• Words Matter: Preferred Language for Talking About Addiction | National Institute on Drug Abuse (NIDA) (nih.gov)
  
  

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
CE Office
Dartmouth Health
[email protected]

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.